Pathos

NEWS

the businessman is watering money tree made by us dollar bills. Business, saving, growth, economic concept. Investors strategy, funding symbol. Copy space

Venture capital

The Top Five Biopharma Venture Capital Raises of H1, 2025

Though nerves abound for funders and founders in the industry, money continues to flow into startups, sometimes in eye-popping numbers. BioSpace rounds up the biggest raises so far this year.

July 30, 2025

·

3 min read

·

Dan Samorodnitsky

IN THE PRESS

Press Releases

Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology

April 23, 2025

·

5 min read

Press Releases

Pathos AI Doses First Patient in Phase 1b/2a Clinical Trial of Pocenbrodib, a CBP/p300 Inhibitor

March 20, 2025

·

3 min read

Press Releases

Pathos Expands Pipeline With Worldwide License of Phase 2-ready Brain-penetrant, PRMT5 Inhibitor

August 15, 2024

·

3 min read

Deals

Pathos AI Completes Acquisition of Rain Oncology

January 26, 2024

·

4 min read

JOBS